Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Tables)

v3.24.1
Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Identifiable Intangible Assets Carrying Value

The net carrying value of the identifiable intangible assets from all acquisitions within continuing operations as of December 31, 2023 and December 31, 2022 are as follows:

 

         

As of

December 31, 2023

   

As of

December 31, 2022

 
    Life     Carrying     Carrying  
    (Years)     Amount     Amount  
                   
Asuragen acquisition:                        
Thyroid     9     $ 8,519     $ 8,519  
RedPath acquisition:                        
Pancreas test     7       16,141       16,141  
Barrett’s test     9       6,682       6,682  
                         
CLIA Lab     2.3       609       609  
                         
Total           $ 31,951     $ 31,951  
                         
Accumulated Amortization             (31,951 )     (31,090 )
                         
Net Carrying Value           $ -     $ 861